At Vanguard Rare Disease Foundation, we believe the process is our product—a revolutionary approach where the methods used to create therapies are just as transformative as the treatments themselves.

We are reimagining drug development for children with ultra-rare diseases by challenging conventional timelines, dismantling systemic barriers, and advancing bold, patient-first clinical models. Our work focuses on designing and launching N-of-1 trials—customized, single-patient studies that can deliver lifesaving treatments to children who have no other options.

Your donation directly powers:

Protocol and trial design tailored to individual patients
Regulatory strategy and preclinical research
Family support and stakeholder coordination
First-in-child treatment pathways never attempted before

By embracing innovative science and creative regulatory frameworks, we are building a new system from the ground up—faster, smarter, and focused on urgent need.

For families waiting on hope, we don’t wait—we make hope happen.

Vanguard Clinical Rare Disease Foundation

Active campaigns

Project Poppy

Hope Takes Flight